Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: do we care?

van Griensven J, Sopheak T, Aseffa Y, Van Damme W, Lynen L.

Trans R Soc Trop Med Hyg. 2010 Oct;104(10):690-2; author reply 692-3. doi: 10.1016/j.trstmh.2010.07.006. Epub 2010 Aug 30. No abstract available.

PMID:
20800253
2.

Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment.

Ioannidis JP, Bassett R, Hughes MD, Volberding PA, Sacks HS, Lau J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):22-30.

PMID:
9377121
3.

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.

Djomand G, Roels T, Ellerbrock T, Hanson D, Diomande F, Monga B, Maurice C, Nkengasong J, Konan-Koko R, Kadio A, Wiktor S, Lackritz E, Saba J, Chorba T.

AIDS. 2003 Jul;17 Suppl 3:S5-15.

PMID:
14565604
5.

[How and why should adherence to antiretroviral therapy].

Knobel H.

Enferm Infecc Microbiol Clin. 2002 Dec;20(10):481-3. Spanish. No abstract available.

PMID:
12433348
6.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
8.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

9.

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.

Diomandé FV, Bissagnéné E, Nkengasong JN, Maurice C, Monga B, Laga M, Nolan ML.

AIDS. 2003 Jul;17 Suppl 3:S87-93.

PMID:
14565614
10.

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.

Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A.

AIDS. 2007 Jan 30;21(3):351-9.

PMID:
17255742
11.

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.

Nellen JF, Wit FW, De Wolf F, Jurriaans S, Lange JM, Prins JM.

J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):943-50.

PMID:
15220701
12.

Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.

Diabaté S, Alary M.

HIV Med. 2009 Nov;10(10):640-6. doi: 10.1111/j.1468-1293.2009.00736.x. Epub 2009 Jul 29.

13.

CD4 cell count recovery in HIV/TB co-infected patients versus TB uninfected HIV patients.

Wanchu A, Kuttiatt VS, Sharma A, Singh S, Varma S.

Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):745-9. doi: 10.4103/0377-4929.72070.

14.

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

Antivir Ther. 2003 Oct;8(5):379-84.

PMID:
14640384
15.
16.

Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy.

Kitahata MM, Van Rompaey SE, Shields AW.

J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):106-14.

PMID:
10935685
17.

Antiretroviral therapy in human immunodeficiency virus-infected individuals.

Spooner KM.

Adv Intern Med. 1998;43:373-402. Review. No abstract available.

PMID:
9506188
18.
19.

Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.

Barreiro PM, Dona MC, Castilla J, Soriano V.

AIDS. 1999 Mar 11;13(4):525-6. No abstract available.

PMID:
10197384
20.

Mortality analysis of HIV-1 infected patients for prioritizing antiretroviral drug therapy.

Pathipvanich P, Rojanawiwat A, Ariyoshi K, Miura T, Pumpradit W, Wongchoosie S, Yingseree P, Warachit P, Sawanpanyalert P.

J Med Assoc Thai. 2004 Aug;87(8):951-4.

PMID:
15471301
Items per page

Supplemental Content

Write to the Help Desk